ClearPoint Neuro, Inc.
CLPT
$10.00
-$0.40-3.85%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.19% | -4.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.19% | -4.32% | |||
| Cost of Revenue | 11.43% | -8.12% | |||
| Gross Profit | 7.77% | -1.75% | |||
| SG&A Expenses | 12.54% | 4.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.52% | 0.61% | |||
| Operating Income | -9.98% | -8.35% | |||
| Income Before Tax | -11.55% | -8.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.88% | -8.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.88% | -8.28% | |||
| EBIT | -9.98% | -8.35% | |||
| EBITDA | -12.98% | -9.29% | |||
| EPS Basic | -11.37% | -8.26% | |||
| Normalized Basic EPS | -11.07% | -8.25% | |||
| EPS Diluted | -11.37% | -8.26% | |||
| Normalized Diluted EPS | -11.07% | -8.25% | |||
| Average Basic Shares Outstanding | 0.47% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.47% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||